表紙：点眼薬の世界市場：タイプ別、医薬品クラス別、疾患別、流通チャネル別、地域別、競合予測と機会（2027年）

市場調査レポート

商品コード

1073074

点眼薬の世界市場：タイプ別、医薬品クラス別、疾患別、流通チャネル別、地域別、競合予測と機会（2027年）

Global Eye Drop Market, By Type, By Drug Class, By Disease Indication, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2027

出版日: 2022年05月01日 | 発行: TechSci Research

| ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 4,900 766,997円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷はできません。

PDF and Excel (Multi-User License)

USD 5,900 923,527円

レポートPDFおよびExcelデータシートを企業内でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。レポート内のデータを含むExcelが併せて納品されます。Excelはライセンスを付与された企業の社内でのご利用が可能です。PDF内コンテンツの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF and Excel (Custom Research License)

USD 8,900 1,393,117円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の点眼薬の市場規模は、2021年に135億3,000万米ドルとなり、予測期間中に6.46％のCAGRで推移し、2027年までには197億5,800万米ドルに達すると予測されています。

同市場は、人々の眼感染症事例の増加により成長すると予想されています。

目の乾燥、充血、目のかゆみ、結膜炎、痛み、緑内障などの眼科疾患の有病率の高さ、およびスマートフォン、ラップトップ、テレビ、電子機器の過度なスクリーンタイムと普及が、今後5年間の同市場の成長をさらに後押しします。また、人口の可処分所得の増加も市場の成長を支えると期待されています。製品製造における技術的進歩、製品の容易な流通による物流部門の拡大が、予測期間中の同市場の成長をさらに促進すると考えられています。

当レポートでは、世界の点眼薬市場について調査し、市場の概要とともに、タイプ別・医薬品クラス別・疾患別・流通チャネル別・地域別の動向、競合動向、および市場に参入する企業のプロファイルなどを提供しています。

市場規模と予測
- 金額ベース
市場シェアと予測
- タイプ別（処方箋 v/s 店頭販売）
- 医薬品クラス別（抗アレルギー、抗炎症、抗緑内障、抗VEGF、その他）
- 疾患別（ドライアイ、緑内障、眼アレルギー、眼感染症、網膜障害、その他）
- 流通チャネル別（病院薬局、小売薬局、オンライン薬局）
- 地域別
- 企業別（2021年）
製品市場マップ

第7章北米の点眼薬市場の見通し

市場規模と予測
- 金額ベース
市場シェアと予測
- タイプ別
- 医薬品クラス別
- 疾患別
- 流通チャネル別
- 国別
北米：国別分析
- 米国
- カナダ
- メキシコ

第8章欧州の点眼薬市場の見通し

市場規模と予測
- 金額ベース
市場シェアと予測
- タイプ別
- 医薬品クラス別
- 疾患別
- 国別
欧州：国別分析
- ロシア
- 英国
- ドイツ
- フランス
- スペイン
- イタリア

第9章アジア太平洋の点眼薬市場の見通し

市場規模と予測
- 金額ベース
市場シェアと予測
- タイプ別
- 医薬品クラス別
- 疾患別
- 流通チャネル別
- 国別
アジア太平洋：国別分析
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- インドネシア

第10章南米の点眼薬市場の見通し

市場規模と予測
- 金額ベース
市場シェアと予測
- タイプ別
- 医薬品クラス別
- 疾患別
- 流通チャネル別
- 国別
南米：国別分析
- ブラジル
- アルゼンチン
- コロンビア

第11章中東・アフリカの点眼薬市場の見通し

市場規模と予測
- 金額ベース
市場シェアと予測
- タイプ別
- 医薬品クラス別
- 疾患別
- 流通チャネル別
- 国別
中東・アフリカ：国別分析
- トルコ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第12章市場力学

促進要因
課題

第13章市場の動向と発展

第14章競合情勢

Johnson & Johnson Inc.
Genentech, Inc. (Roche)
Alcon Inc.
Pfizer, Inc.
Bausch Health Companies, Inc.
Bayer Corporation
Allergan, Inc. (AbbVie)
Abbott Laboratories Inc.
KC Pharmaceuticals, Inc.
Akorn, Inc.

第15章戦略的推奨事項

第16章免責事項

図表

List of Figures

Figure 1: Global Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 3: Global Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 4: Global Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 5: Global Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 6: Global Eye Drop Market Share, By Region, By Value, 2017-2027F
Figure 7: Global Eye Drop Market Share, By Company, By Value, 2021
Figure 8: Global Eye Drop Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Eye Drop Market Map, By Drug Class, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Eye Drop Market Map, By Disease Indication, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: Global Eye Drop Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Eye Drop Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: North America Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 14: North America Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 15: North America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 16: North America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 17: North America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 18: North America Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 19: United States Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 20: United States Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 21: United States Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 22: United States Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 23: United States Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 24: Canada Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 25: Canada Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 26: Canada Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 27: Canada Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 28: Canada Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: Mexico Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 30: Mexico Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 31: Mexico Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 32: Mexico Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 33: Mexico Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 34: Europe Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 35: Europe Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 36: Europe Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 37: Europe Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 38: Europe Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 39: Europe Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 40: Russia Federation Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 41: Russia Federation Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 42: Russia Federation Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 43: Russia Federation Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 44: Russia Federation Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 45: United Kingdom Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 46: United Kingdom Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 47: United Kingdom Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 48: United Kingdom Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 49: United Kingdom Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 50: Germany Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 51: Germany Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 52: Germany Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 53: Germany Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 54: Germany Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 55: France Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 56: France Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 57: France Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 58: France Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 59: France Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 60: Spain Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 61: Spain Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 62: Spain Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 63: Spain Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 64: Spain Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 65: Italy Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 66: Italy Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 67: Italy Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 68: Italy Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 69: Italy Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 70: Asia-Pacific Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 71: Asia-Pacific Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 72: Asia-Pacific Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 73: Asia-Pacific Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 74: Asia-Pacific Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 75: Asia-Pacific Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 76: China Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 77: China Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 78: China Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 79: China Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 80: China Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 81: India Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 82: India Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 83: India Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 84: India Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 85: India Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 86: Japan Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 87: Japan Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 88: Japan Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 89: Japan Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 90: Japan Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 91: Australia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 92: Australia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 93: Australia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 94: Australia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 95: Australia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 96: South Korea Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 97: South Korea Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 98: South Korea Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 99: South Korea Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 100: South Korea Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 101: Indonesia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 102: Indonesia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 103: Indonesia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 104: Indonesia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 105: Indonesia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 106: South America Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 107: South America Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 108: South America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 109: South America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 110: South America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 111: South America Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 112: Brazil Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 113: Brazil Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 114: Brazil Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 115: Brazil Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 116: Brazil Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 117: Argentina Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 118: Argentina Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 119: Argentina Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 120: Argentina Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 121: Argentina Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 122: Colombia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 123: Colombia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 124: Colombia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 125: Colombia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 126: Colombia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 127: Middle East & Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 128: Middle East & Africa Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 129: Middle East & Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 130: Middle East & Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 131: Middle East & Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 132: Middle East & Africa Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 133: Turkey Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 134: Turkey Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 135: Turkey Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 136: Turkey Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 137: Turkey Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 138: South Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 139: South Africa Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 140: South Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 141: South Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 142: South Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 143: Saudi Arabia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 144: Saudi Arabia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 145: Saudi Arabia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 146: Saudi Arabia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 147: Saudi Arabia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 148: UAE Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 149: UAE Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 150: UAE Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 151: UAE Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 152: UAE Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 153: Kuwait Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 154: Kuwait Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 155: Kuwait Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 156: Kuwait Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 157: Kuwait Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Product Code: 4539

Global eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027. The market is anticipated to grow on account of increasing instances of eye infection in the population. Higher prevalence of eye diseases like eye dryness, redness, itching in the eyes, conjunctivitis, soreness, glaucoma, etc. further drive the growth of the global eye drop market in the upcoming five years. Excessive screen time and penetration of smart phones, laptops, television, and electronics further supports the growth of the global eye drop market in the next five years. The governments around the world are actively investing in the healthcare industry and increasing the production of the pharmaceuticals and therapeutics products in the recent years. Growing imports & exports of the pharmaceutical & therapeutics products like eye drops further aid the growth of the global eye drop market in the future five years. Also, the consumers in the country have been spending over healthcare services to attain excellent patient care. Rising disposable income of the population also sustains the market growth. Technological advancement in product manufacturing, expanding logistics sector with easy distribution of the products further aids the growth of the global eye drop market in the forecast period.

The global eye drop market is segmented by type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution. Based on type, the market is further differentiated into prescription and over the counter. Prescription type eye drops are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on account of increasing instances of eye diseases. Increasing instances of diabetes and thus higher risks of catching eye diseases, vision impairment, also aids to the growth of the segment. Over the counter eye drops are expected to achieve the fastest growth owing to increasing tendency of the consumers to self-medicate their conditions of eye burning sensations and redness, etc. Increasing common eye itchiness and dryness due to prolonged screen times also aid to the growth of the sub-segment along with the growth of the global eye drops market in the future five years.

Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc. are among the major market players in the global eye drop market.

Years considered for this report:

Historical Years: 2017- 2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F - 2027F

Objective of the Study:

To analyze the historical growth in the market size of global eye drop market from 2017 to 2021.
To estimate and forecast the market size of global eye drop market from 2022E to 2027F and growth rate until 2027F.
To classify and forecast global eye drop market based on type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution.
To identify dominant region or segment in the global eye drop market.
To identify drivers and challenges for global eye drop market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global eye drop market.
To identify and analyze the profile of leading players operating in global eye drop market.
To identify key sustainable strategies adopted by market players in global eye drop market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global eye drop market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Eye drops manufacturers and suppliers
Distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to eye drops
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global eye drop market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Eye Drop Market, By Type:

Prescription

Over-The-Counter

Eye Drop Market, By Drug Class:

Anti-allergy

Anti-glaucoma

Anti-inflammatory

Anti-VEGF

Others

Eye Drop Market, By Disease Indication:

Eye Allergy

Glaucoma

Eye Infections

Dry Eye Diseases

Retinal Disorders

Eye Drop Market, By Distribution Channel:

Hospitals Pharmacy

Retail Pharmacy

Online Pharmacy

Eye Drop Market, By Region:

North America

United States
Canada
Mexico

Europe

Russia Federation
United Kingdom
Germany
France
Spain
Italy

Asia-Pacific

China
India
Japan
Australia
South Korea
Indonesia

South America

Brazil
Argentina
Colombia

Middle East & Africa

Turkey
South Africa
Saudi Arabia
UAE
Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global eye drop market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Eye Drop Market

5. Voice of Customer

5.1. Brand Awareness
5.2. Factors Contributing to demand for Eye Drops
5.3. Demand, By Drug Class
5.4. Demand, By Disease Indication
5.5. Preference, By Distribution Channel

6. Global Eye Drop Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type (Prescription v/s Over-The-Counter)
- 6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)
- 6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
- 6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
- 6.2.5. By Region
- 6.2.6. By Company (2021)
6.3. Product Market Map

7. North America Eye Drop Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Drug Class
- 7.2.3. By Disease Indication
- 7.2.4. By Distribution Channel
- 7.2.5. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Eye Drop Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Drug Class
    - 7.3.1.2.3. By Disease Indication
    - 7.3.1.2.4. By Distribution Channel
- 7.3.2. Canada Eye Drop Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Drug Class
    - 7.3.2.2.3. By Disease Indication
    - 7.3.2.2.4. By Distribution Channel
- 7.3.3. Mexico Eye Drop Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Drug Class
    - 7.3.3.2.3. By Disease Indication
    - 7.3.3.2.4. By Distribution Channel

8. Europe Eye Drop Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Drug Class
- 8.2.3. By Disease Indication
- 8.2.4. By Country
8.3. Europe: Country Analysis
- 8.3.1. Russia Federation Eye Drop Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Drug Class
    - 8.3.1.2.3. By Disease Indication
    - 8.3.1.2.4. By Distribution Channel
- 8.3.2. United Kingdom Eye Drop Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Drug Class
    - 8.3.2.2.3. By Disease Indication
    - 8.3.2.2.4. By Distribution Channel
- 8.3.3. Germany Eye Drop Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Drug Class
    - 8.3.3.2.3. By Disease Indication
    - 8.3.3.2.4. By Distribution Channel
- 8.3.4. France Eye Drop Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Drug Class
    - 8.3.4.2.3. By Disease Indication
    - 8.3.4.2.4. By Distribution Channel
- 8.3.5. Spain Eye Drop Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Drug Class
    - 8.3.5.2.3. By Disease Indication
    - 8.3.5.2.4. By Distribution Channel
- 8.3.6. Italy Eye Drop Market Outlook
  - 8.3.6.1. Market Size & Forecast
    - 8.3.6.1.1. By Value
  - 8.3.6.2. Market Share & Forecast
    - 8.3.6.2.1. By Type
    - 8.3.6.2.2. By Drug Class
    - 8.3.6.2.3. By Disease Indication
    - 8.3.6.2.4. By Distribution Channel

9. Asia-Pacific Eye Drop Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Drug Class
- 9.2.3. By Disease Indication
- 9.2.4. By Distribution Channel
- 9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Eye Drop Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Drug Class
    - 9.3.1.2.3. By Disease Indication
    - 9.3.1.2.4. By Distribution Channel
- 9.3.2. India Eye Drop Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Drug Class
    - 9.3.2.2.3. By Disease Indication
    - 9.3.2.2.4. By Distribution Channel
- 9.3.3. Japan Eye Drop Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Drug Class
    - 9.3.3.2.3. By Disease Indication
    - 9.3.3.2.4. By Distribution Channel
- 9.3.4. Australia Eye Drop Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Type
    - 9.3.4.2.2. By Drug Class
    - 9.3.4.2.3. By Disease Indication
    - 9.3.4.2.4. By Distribution Channel
- 9.3.5. South Korea Eye Drop Market Outlook
  - 9.3.5.1. Market Size & Forecast
    - 9.3.5.1.1. By Value
  - 9.3.5.2. Market Share & Forecast
    - 9.3.5.2.1. By Type
    - 9.3.5.2.2. By Drug Class
    - 9.3.5.2.3. By Disease Indication
    - 9.3.5.2.4. By Distribution Channel
- 9.3.6. Indonesia Eye Drop Market Outlook
  - 9.3.6.1. Market Size & Forecast
    - 9.3.6.1.1. By Value
  - 9.3.6.2. Market Share & Forecast
    - 9.3.6.2.1. By Type
    - 9.3.6.2.2. By Drug Class
    - 9.3.6.2.3. By Disease Indication
    - 9.3.6.2.4. By Distribution Channel

10. South America Eye Drop Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Drug Class
- 10.2.3. By Disease Indication
- 10.2.4. By Distribution Channel
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Eye Drop Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Drug Class
    - 10.3.1.2.3. By Disease Indication
    - 10.3.1.2.4. By Distribution Channel
- 10.3.2. Argentina Eye Drop Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Drug Class
    - 10.3.2.2.3. By Disease Indication
    - 10.3.2.2.4. By Distribution Channel
- 10.3.3. Colombia Eye Drop Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Drug Class
    - 10.3.3.2.3. By Disease Indication
    - 10.3.3.2.4. By Distribution Channel

11. Middle East and Africa Eye Drop Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Drug Class
- 11.2.3. By Disease Indication
- 11.2.4. By Distribution Channel
- 11.2.5. By Country
11.3. MEA: Country Analysis
- 11.3.1. Turkey Eye Drop Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Type
    - 11.3.1.2.2. By Drug Class
    - 11.3.1.2.3. By Disease Indication
    - 11.3.1.2.4. By Distribution Channel
- 11.3.2. South Africa Eye Drop Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Type
    - 11.3.2.2.2. By Drug Class
    - 11.3.2.2.3. By Disease Indication
    - 11.3.2.2.4. By Distribution Channel
- 11.3.3. Saudi Arabia Eye Drop Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Type
    - 11.3.3.2.2. By Drug Class
    - 11.3.3.2.3. By Disease Indication
    - 11.3.3.2.4. By Distribution Channel
- 11.3.4. UAE Eye Drop Market Outlook
  - 11.3.4.1. Market Size & Forecast
    - 11.3.4.1.1. By Value
  - 11.3.4.2. Market Share & Forecast
    - 11.3.4.2.1. By Type
    - 11.3.4.2.2. By Drug Class
    - 11.3.4.2.3. By Disease Indication
    - 11.3.4.2.4. By Distribution Channel
- 11.3.5. Kuwait Eye Drop Market Outlook
  - 11.3.5.1. Market Size & Forecast
    - 11.3.5.1.1. By Value
  - 11.3.5.2. Market Share & Forecast
    - 11.3.5.2.1. By Type
    - 11.3.5.2.2. By Drug Class
    - 11.3.5.2.3. By Disease Indication
    - 11.3.5.2.4. By Distribution Channel

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Johnson & Johnson Inc.
14.2. Genentech, Inc. (Roche)
14.3. Alcon Inc.
14.4. Pfizer, Inc.
14.5. Bausch Health Companies, Inc.
14.6. Bayer Corporation
14.7. Allergan, Inc. (AbbVie)
14.8. Abbott Laboratories Inc.
14.9. KC Pharmaceuticals, Inc.
14.10. Akorn, Inc.

点眼薬の世界市場：タイプ別、医薬品クラス別、疾患別、流通チャネル別、地域別、競合予測と機会（2027年）

Global Eye Drop Market, By Type, By Drug Class, By Disease Indication, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2027

目次

第1章製品の概要

第2章調査手法

第3章エグゼクティブサマリー

第4章 COVID-19の世界の点眼薬市場への影響

第5章 VOC (顧客の声)

第6章世界の点眼薬市場の見通し

第7章北米の点眼薬市場の見通し

第8章欧州の点眼薬市場の見通し

第9章アジア太平洋の点眼薬市場の見通し

第10章南米の点眼薬市場の見通し

第11章中東・アフリカの点眼薬市場の見通し

第12章市場力学

第13章市場の動向と発展

第14章競合情勢

第15章戦略的推奨事項

第16章免責事項

List of Figures

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Eye Drop Market

5. Voice of Customer

6. Global Eye Drop Market Outlook

7. North America Eye Drop Market Outlook

8. Europe Eye Drop Market Outlook

9. Asia-Pacific Eye Drop Market Outlook

10. South America Eye Drop Market Outlook

11. Middle East and Africa Eye Drop Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

点眼薬の世界市場：タイプ別、医薬品クラス別、疾患別、流通チャネル別、地域別、競合予測と機会（2027年）

Global Eye Drop Market, By Type, By Drug Class, By Disease Indication, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2027

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19の世界の点眼薬市場への影響

第5章 VOC (顧客の声)

第6章 世界の点眼薬市場の見通し

第7章 北米の点眼薬市場の見通し

第8章 欧州の点眼薬市場の見通し

第9章 アジア太平洋の点眼薬市場の見通し

第10章 南米の点眼薬市場の見通し

第11章 中東・アフリカの点眼薬市場の見通し

第12章 市場力学

第13章 市場の動向と発展

第14章 競合情勢

第15章 戦略的推奨事項

第16章 免責事項

List of Figures

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Eye Drop Market

5. Voice of Customer

6. Global Eye Drop Market Outlook

7. North America Eye Drop Market Outlook

8. Europe Eye Drop Market Outlook

9. Asia-Pacific Eye Drop Market Outlook

10. South America Eye Drop Market Outlook

11. Middle East and Africa Eye Drop Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

第1章製品の概要

第2章調査手法

第3章エグゼクティブサマリー

第6章世界の点眼薬市場の見通し

第7章北米の点眼薬市場の見通し

第8章欧州の点眼薬市場の見通し

第9章アジア太平洋の点眼薬市場の見通し

第10章南米の点眼薬市場の見通し

第11章中東・アフリカの点眼薬市場の見通し

第12章市場力学

第13章市場の動向と発展

第14章競合情勢

第15章戦略的推奨事項

第16章免責事項